◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT05473858 |
| Status | Recruiting |
| Phase | Phase 3 |
| Sponsor | sara nabil |
| Condition | Reversal of Local Anesthesia in Children |
| Study Type | INTERVENTIONAL |
| Enrollment | 36 participants |
| Start Date | 2021-12-10 |
| Primary Completion | 2026-04-10 |
Trial Parameters
Condition Reversal of Local Anesthesia in Children
Sponsor sara nabil
Study Type INTERVENTIONAL
Phase Phase 3
Enrollment 36
Sex ALL
Min Age 6 Years
Max Age 10 Years
Start Date 2021-12-10
Completion 2026-04-10
Interventions
OraVerse Injectable Productdiode laserAnaesthesia only
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
clinically assess the reversal of articaine 4% of two different concentration of vasoconcentration soft-tissue local anesthesia in pediatric dentistry using Diode Laser and Oraverse
Eligibility Criteria
Inclusion Criteria: 1. Patients who need to be treated under anesthesia by injecting mandibular first molar infiltration. 2. Cooperative children aged 6 to 10 years old with the ability to understand and respond to the sensation of soft tissue -
Related Trials
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology